Cipher Pharmaceuticals

(TSX) CPH

Current PriceCA$16.63

Market CapCA$422.70M

Since IPO (2004)+352%

5 Year+920%

1 Year+31%

1 Month-15%

Cipher Pharmaceuticals Financials at a Glance

Market Cap

CA$422.70M

Revenue (TTM)

$50.92M

Net Income (TTM)

$30.97M

EPS (TTM)

CA$1.65

P/E Ratio

9.94

Dividend

CA$0.00

Beta (Volatility)

0.48 (Low)

Dividend

CA$0.00

Beta (Volatility)

0.48 (Low)

Price

CA$16.63

Volume

1,271

Open

CA$16.58

Price

CA$16.63

Volume

1,271

Open

CA$16.58

Previous Close

CA$16.72

Daily Range

CA$16.49 - CA$16.63

52-Week Range

CA$11.98 - CA$20.56

Estimated Earnings Date

Aug 6, 2026

Dividend

CA$0.00

Beta (Volatility)

0.48 (Low)

Price

CA$16.63

Volume

1,271

Open

CA$16.58

Previous Close

CA$16.72

Daily Range

CA$16.49 - CA$16.63

52-Week Range

CA$11.98 - CA$20.56

Estimated Earnings Date

Aug 6, 2026

CPH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cipher Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Craig Mull

Website

www.cipherpharma.com

Headquarters

Mississauga, ON L6H 0M2, CA

CPH Financials

Key Financial Metrics (TTM)

Gross Margin

75%

Operating Margin

39%

Net Income Margin

61%

Return on Equity

25%

Return on Capital

15%

Return on Assets

20%

Earnings Yield

10.06%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

CA$422.70M

Shares Outstanding

25.28M

Volume

1.27K

Avg. Volume

32.25K

Financials (TTM)

Gross Profit

$33.77M

Operating Income

$16.80M

EBITDA

$16.80M

Operating Cash Flow

$30.25M

Capital Expenditure

-$28.49K

Free Cash Flow

$30.22M

Cash & ST Invst.

$7.48M

Total Debt

$5.49M

Cipher Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$12.30M

+2.3%

Gross Profit

$8.35M

-8.6%

Gross Margin

67.89%

N/A

Market Cap

CA$422.70M

N/A

Market Cap/Employee

CA$84.54M

N/A

Employees

N/A

Net Income

$6.06M

+131.0%

EBITDA

$7.28M

+69.5%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$5.99M

+132.3%

Accounts Receivable

$9.76M

-17.1%

Inventory

$8.20M

+48.2%

Long Term Debt

$165.12K

-99.6%

Short Term Debt

$263.19K

-1.4%

Return on Assets

20.19%

N/A

Return on Invested Capital

14.84%

N/A

Free Cash Flow

$4.45M

+5.4%

Operating Cash Flow

$4.45M

+5.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NGEN.VNervGen Pharma Corp.

NGEN.VNervGen Pharma Corp.CA$5.15+3.00%

TSND.TOTerrAscend Corp.

TSND.TOTerrAscend Corp.CA$1.02-0.97%

HITI.VHigh Tide Inc.

HITI.VHigh Tide Inc.CA$3.27+0.31%

ACB.TOAurora Cannabis Inc.

ACB.TOAurora Cannabis Inc.CA$4.73+0.00%

WEED.TOCanopy Growth Corporation

WEED.TOCanopy Growth CorporationCA$1.45+0.00%

OGI.TOOrganiGram Holdings Inc.

OGI.TOOrganiGram Holdings Inc.CA$1.52+0.66%

GUD.TOKnight Therapeutics Inc.

GUD.TOKnight Therapeutics Inc.CA$9.30+1.09%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.02+0.01%

NOKNokia

NOKNokia$13.79-0.00%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$72.76-0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.79-0.02%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.62+0.04%

ONDSOndas

ONDSOndas$9.85+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.81-0.02%

Questions About CPH

What is the current price of Cipher Pharmaceuticals?

Cipher Pharmaceuticals is trading at CA$16.63 per share.

What is the 52-week range for Cipher Pharmaceuticals?

Over the past 52 weeks, Cipher Pharmaceuticals has traded between CA$11.98 and CA$20.56.

How much debt does Cipher Pharmaceuticals have?

As of the most recent reporting period, Cipher Pharmaceuticals reported total debt of $597.30K.

How much cash does Cipher Pharmaceuticals have on hand?

Cipher Pharmaceuticals reported $8.95M in cash and cash equivalents in its most recent financial results.

What is Cipher Pharmaceuticals’s dividend yield?

Cipher Pharmaceuticals does not currently have a dividend yield.

Cipher Pharmaceuticals

Cipher Pharmaceuticals Financials at a Glance

CPH News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cipher Pharmaceuticals

CPH Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cipher Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CPH

What is the current price of Cipher Pharmaceuticals?

What is the 52-week range for Cipher Pharmaceuticals?

How much debt does Cipher Pharmaceuticals have?

How much cash does Cipher Pharmaceuticals have on hand?

What is Cipher Pharmaceuticals’s dividend yield?

Premium Investing Services